Mediclinic International

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Sunday, January 22, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Sunday, January 22, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Sunday, January 22, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Sunday, January 22, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Sunday, January 22, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Sunday, January 22, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Sunday, December 18, 2022

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Sunday, December 18, 2022

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Sunday, December 18, 2022

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Sunday, December 18, 2022

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.